{
    "clinical_study": {
        "@rank": "158164", 
        "arm_group": [
            {
                "arm_group_label": "oocyte vitrification", 
                "arm_group_type": "Experimental", 
                "description": "All retrieved mature oocytes will be vitrified."
            }, 
            {
                "arm_group_label": "embryo freezing", 
                "arm_group_type": "Active Comparator", 
                "description": "All retrieved oocytes will be fertilized, and resulting embryos will be frozen."
            }
        ], 
        "brief_summary": {
            "textblock": "The chances to achieve pregnancy after retrieving >15 oocytes are not good, probably because\n      of bad effect on the endometrium (uterine inner lining). Therefore, in most such cases the\n      investigators prefer to freeze all embryos, and transfer in a thaw cycle. With the\n      introduction of oocyte vitrification (very fast cooling)  technology, a new option emerged:\n      to freeze un-fertilized eggs, to be fertilized and used later in a thaw cycle.\n\n      The purpose of this study is to compare the outcome of these two approaches."
        }, 
        "brief_title": "IVF Hyper-responders: Oocyte Vitrification Compared With Embryo Freezing", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Infertility", 
        "condition_browse": {
            "mesh_term": "Infertility"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  IVF patients\n\n          -  ovulation trigger with Decapeptyl 0.2 mg because of ovarian hyper-response: E2 on\n             trigger day .12,000 pmol/l and/or >15 oocytes.\n\n          -  Normal uterus\n\n        Exclusion Criteria:\n\n          -  <20% fertilization rate"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "40 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02026193", 
            "org_study_id": "RMB-0439-13"
        }, 
        "intervention": [
            {
                "arm_group_label": "oocyte vitrification", 
                "intervention_name": "oocyte vitrification", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "embryo freezing", 
                "intervention_name": "embryo freezing", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 29, 2014", 
        "location": {
            "contact": {
                "email": "skol@rambam.health.gov.il", 
                "last_name": "Shahar Kol, Assistant professor", 
                "phone": "972-4-8543232"
            }, 
            "facility": {
                "address": {
                    "city": "Haifa", 
                    "country": "Israel", 
                    "zip": "31096"
                }, 
                "name": "IVF Unit, Rambam medical Center"
            }, 
            "investigator": {
                "last_name": "Shahar Kol, assistant professor", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "skol@rambam.health.gov.il", 
            "last_name": "Shahar Kol, Assistant professor", 
            "phone": "972-4-8543232"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Fetal heart activity 1 month post embryo transfer", 
            "safety_issue": "No", 
            "time_frame": "1 month after embryo transfer"
        }, 
        "reference": {
            "PMID": "21828116", 
            "citation": "Devroey P, Polyzos NP, Blockeel C. An OHSS-Free Clinic by segmentation of IVF treatment. Hum Reprod. 2011 Oct;26(10):2593-7. doi: 10.1093/humrep/der251. Epub 2011 Aug 9. Review."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02026193"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Rambam Health Care Campus", 
            "investigator_full_name": "Shahar Kol MD", 
            "investigator_title": "Director, IVF Unit", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Rambam Health Care Campus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Rambam Health Care Campus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}